Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study — Stella

Recruiting

Back to Neuromyelitis Optica Spectrum Disorder Attack trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

the First Medical Center of Chinese PLA General Hospital, Beijing

Key details

Phase

Post-approval study

Sponsor

Chinese PLA General Hospital

Enrollment target

~200 participants

Started

February 2026

Primary completion

June 2027

Age range

18 Years – 65 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov